Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents

Inan, UU; ÖZTÜRK, FARUK; Kaynak, S; Kurt, E; Emiroglu, L; Ozer, E; Ilker, SS; Guler, C

doi:10.1016/s0886-3350(00)00886-5

Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents

Copy For Citation

Inan U., ÖZTÜRK F., Kaynak S., Kurt E., Emiroglu L., Ozer E., ...More

JOURNAL OF CATARACT AND REFRACTIVE SURGERY, vol.27, no.7, pp.1079-1087, 2001 (SCI-Expanded)

Publication Type: Article / Article
Volume: 27 Issue: 7
Publication Date: 2001
Doi Number: 10.1016/s0886-3350(00)00886-5
Journal Name: JOURNAL OF CATARACT AND REFRACTIVE SURGERY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1079-1087
Dokuz Eylül University Affiliated: No

Abstract

Purpose. To determine whether an intraoperative single dose of dexamethasone, diclofenac, ethylenediaminetetraacetic acid (EDTA), a combination of EDTA and RGD peptide (arginine-glycin-aspartic acid sequence), or mitomycin-C (MMC) is a pharmacological means of preventing or reducing the development of posterior capsule opacification (PCO).